Correlation Between Karyopharm Therapeutics and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Caribou Biosciences, you can compare the effects of market volatilities on Karyopharm Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Caribou Biosciences.
Diversification Opportunities for Karyopharm Therapeutics and Caribou Biosciences
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Karyopharm and Caribou is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Caribou Biosciences
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Caribou Biosciences. In addition to that, Karyopharm Therapeutics is 1.05 times more volatile than Caribou Biosciences. It trades about -0.03 of its total potential returns per unit of risk. Caribou Biosciences is currently generating about -0.03 per unit of volatility. If you would invest 914.00 in Caribou Biosciences on August 25, 2024 and sell it today you would lose (712.00) from holding Caribou Biosciences or give up 77.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. Caribou Biosciences
Performance |
| Timeline |
| Karyopharm Therapeutics |
| Caribou Biosciences |
Karyopharm Therapeutics and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and Caribou Biosciences
The main advantage of trading using opposite Karyopharm Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |